MDRC Share Price Rises 9.99% as MODERN DIAGNOSTIC & RESEARCH C (MDRC) Gains Today
- September 15, 2026
- Posted by: Harsh Piplani
- Category: News
MDRC Share Price rose to Rs 84.77, up 9.99% from the previous close, while the company’s market capitalisation stood at Rs 116.37 crore. Modern Diagnostic & Research C has become a Stock Market Today talking point because the price action is sharp enough to draw attention, even though the verified data does not establish a company-specific catalyst. According to latest Univest data, the move was supported by a turnover of Rs 0.3 crore and an intraday range that stayed tight around the opening level. For readers tracking MDRC Share Price Today, the main question is less about a headline trigger and more about whether valuation, sector positioning and business quality justify continued interest in MDRC Stock News.
The latest Univest figures show that this is a price rise led by market attention rather than a disclosed event, so investors should focus on the company’s financial ratios, healthcare peer context and business profile. Univest will keep the stock on watch as a live market mover within the Indian Stock Market.
MDRC Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 84.77 |
| Previous Close | Rs 77.07 |
| Today's Move | Rs 7.7 (+9.99%) |
| Open | Rs 83.99 |
| High | Rs 84.77 |
| Low | Rs 83 |
| Turnover | Rs 0.3 crore |
| Market Capitalisation | Rs 116.37 crore |
| Market Cap Category | Micro Cap |
MODERN DIAGNOSTIC & RESEARCH C (MDRC) rose to Rs 84.77 from the previous close of Rs 77.07, a move of Rs 7.7 or 9.99%. The stock opened at Rs 83.99, reached a high of Rs 84.77, recorded a low of Rs 83.
MDRC Share Price Today moved from a previous close of Rs 77.07 to Rs 84.77, a gain of Rs 7.70 or 9.99%. The stock opened at Rs 83.99, touched a high of Rs 84.77 and a low of Rs 83.00, which shows that trading stayed close to the day’s upper end. Turnover stood at Rs 0.3 crore, helping place the move in the context of a fast-rising share price rise rather than a broad, noisy market move. For anyone scanning MDRC Share Price updates, the day’s action fits the profile of a stock gaining today and drawing notice in Stocks in News and Top Gainers Today.
MODERN DIAGNOSTIC & RESEARCH C (MDRC) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 116.37 crore |
| P/E Ratio | 22.15x |
| P/B Ratio | 2.02x |
| ROE | 55.21% |
| ROCE | 39% |
| EPS | Rs 3.48 |
| Book Value Per Share | Rs 38.16 |
| Dividend Yield | 0% |
MODERN DIAGNOSTIC & RESEARCH C (MDRC) fundamental metrics show P/E 22.15x, P/B 2.02x, ROE 55.21%, ROCE 39%. These figures provide context only and are not a buy or sell signal.
MODERN DIAGNOSTIC & RESEARCH C has a market capitalisation of Rs 116.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.15x, P/B at 2.02x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 55.21% and ROCE of 39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.48, book value per share of Rs 38.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 47.15x, median ROE of 12.88%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.15x |
| Benchmark Median P/E | 47.15x |
| Benchmark Average P/E | 104.94x |
| Benchmark P/E Range | 7.18x to 1,570.12x |
| Company P/B Ratio | 2.02x |
| Benchmark Median P/B | 2.94x |
| Company ROE | 55.21% |
| Benchmark Median ROE | 12.88% |
| Company ROCE | 39% |
| Benchmark Median ROCE | 15.77% |
| Company Market Capitalisation | Rs 116.37 crore |
| Benchmark Median Market Cap | Rs 488.55 crore |
MODERN DIAGNOSTIC & RESEARCH C (MDRC) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a P/E ratio of 22.15x, which is below the benchmark median of 47.15x, a difference of -53.02%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a ROE of 55.21%, which is above the benchmark median of 12.88%, a difference of +328.65%. MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a ROCE of 39%, which is above the benchmark median of 15.77%, a difference of +147.31%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,27,249.42 | 60.9 | 13.14 | 23.54 | 21.73 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 1,00,951.74 | 69.29 | 9.24 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 94,200.74 | 105.57 | 5.16 | 12.95 | 13.93 |
| Fortis Healthcare Ltd. | FORTIS | 66,987.44 | 63.93 | 6.59 | 11.32 | 14.07 |
| Aster DM Healthcare Ltd. | ASTERDM | 66,504.25 | 384.57 | 15.6 | 7.85 | 11.26 |
MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a P/E ratio of 22.15x compared with the displayed peer median of 69.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 55.21% compares with a peer median of 12.95% across the companies shown in the table. ROCE stood at 39% versus the displayed peer median of 14.07%, providing a capital-efficiency comparison. MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a market capitalisation of Rs 116.37 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching MDRC
- MDRC Share Price rose 9.99% to Rs 84.77, making it a clear intraday gainer.
- The move came with Rs 0.3 crore turnover, so traders are watching how price behaviour develops.
- Valuation metrics are below the sector benchmark median, which keeps MDRC Fundamental Analysis in focus.
- ROE of 55.21% and ROCE of 39% are stronger than the sector medians in the latest Univest data.
- The stock is being tracked within Healthcare, a sector that often features in NSE News and BSE News screens.
About MDRC
Modern Diagnostic & Research C operates in the Healthcare sector and the Hospital & Healthcare Services industry. The business context places it among companies that typically serve diagnostics, healthcare access and related service demand. For readers scanning MDRC Share Price and MDRC Company News, the important point is that the stock belongs to a sector where patient flow, service quality and pricing discipline can matter as much as scale. The latest Univest figures show that MDRC has a market capitalisation of Rs 116.37 crore, making it a smaller listed healthcare name compared with several well-known peers. Its current valuation ratios and profitability metrics suggest a business that the market may be assessing on efficiency and relative pricing rather than only size. That is why MDRC Share Price Today continues to attract interest from investors following MDRC News Today and broader Healthcare Stock News.
Frequently Asked Questions
Why is MDRC Share Price rising today?
Ans. MDRC Share Price rose 9.99% to Rs 84.77 in today’s market. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst for the move.
What is MDRC Share Price Today?
Ans. MDRC Share Price Today is Rs 84.77. It moved up from the previous close of Rs 77.07, which makes the stock one of the day’s notable healthcare gainers.
What is the market capitalisation of MDRC?
Ans. MDRC’s market capitalisation stands at Rs 116.37 crore. That places the company below the sector benchmark median for market cap in the same industry and keeps it in the small-cap category.
How does MDRC look on valuation?
Ans. MDRC’s P/E ratio is 22.15 and its P/B ratio is 2.02. Both are below the sector medians of 47.15 and 2.94, which makes the stock look moderately valued versus peers.
What do ROE and ROCE show for MDRC?
Ans. MDRC reports ROE of 55.21% and ROCE of 39%. These are above the sector medians in the latest Univest figures, indicating strong return ratios compared with the broader healthcare benchmark.
What do EPS and book value mean for MDRC?
Ans. MDRC has EPS of 3.48 and book value of 38.16. EPS shows earnings attributable to each share, while book value indicates the accounting net worth behind each share.
Does MDRC pay a dividend?
Ans. MDRC’s dividend yield is 0. That means the stock’s current investor appeal is linked more to valuation, price movement and business metrics than to a cash yield.
How does MDRC compare with healthcare peers?
Ans. MDRC’s market cap is much smaller than peers such as Apollo Hospitals, Max Healthcare, Fortis and MANIPAL. However, its P/E, P/B, ROE and ROCE compare favourably in the latest Univest peer set.
Track MDRC Share Price on Univest
Use MODERN DIAGNOSTIC & RESEARCH C (MDRC) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track MDRC Share Price Live on Univest for the latest market update, company ratios, sector context and peer comparison. Univest also helps readers monitor MDRC Share Price Today, MDRC Stock Analysis and key company metrics in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
